• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌转移与微环境中的表观遗传修饰

Epigenetic Modifications in Prostate Cancer Metastasis and Microenvironment.

作者信息

Zhang Shouyi, Shen Tao, Zeng Yu

机构信息

Department of Urology, the Cancer Hospital of Dalian University of Technology & Liaoning Cancer Hospital, Shenyang 110042, China.

Department of Urology, Second Affiliated Hospital of Shenyang Medical College, No. 20 Beijiu Road, Heping District, Shenyang 110001, China.

出版信息

Cancers (Basel). 2023 Apr 11;15(8):2243. doi: 10.3390/cancers15082243.

DOI:10.3390/cancers15082243
PMID:37190171
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10137161/
Abstract

The gradual evolution of prostate tissue from benign tumor to malignant lesion or distant metastasis is driven by intracellular epigenetic changes and the tumor microenvironment remodeling. With the continuous study of epigenetic modifications, these tumor-driving forces are being discovered and are providing new treatments for cancer. Here we introduce the classification of epigenetic modification and highlight the role of epigenetic modification in tumor remodeling and communication of the tumor microenvironment.

摘要

前列腺组织从良性肿瘤逐渐演变为恶性病变或远处转移是由细胞内表观遗传变化和肿瘤微环境重塑驱动的。随着对表观遗传修饰的不断研究,这些肿瘤驱动因素正在被发现,并为癌症提供新的治疗方法。在此,我们介绍表观遗传修饰的分类,并强调表观遗传修饰在肿瘤重塑和肿瘤微环境通讯中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb7b/10137161/69ede970dad6/cancers-15-02243-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb7b/10137161/69ede970dad6/cancers-15-02243-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb7b/10137161/69ede970dad6/cancers-15-02243-g001.jpg

相似文献

1
Epigenetic Modifications in Prostate Cancer Metastasis and Microenvironment.前列腺癌转移与微环境中的表观遗传修饰
Cancers (Basel). 2023 Apr 11;15(8):2243. doi: 10.3390/cancers15082243.
2
Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.前列腺癌进展的分子见解:肿瘤微环境的缺失环节
J Urol. 2005 Jan;173(1):10-20. doi: 10.1097/01.ju.0000141582.15218.10.
3
The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.表观遗传学在前列腺癌和良性前列腺增生的发生、诊断及治疗中的作用不断扩展。
J Urol. 2007 Mar;177(3):822-31. doi: 10.1016/j.juro.2006.10.063.
4
Influence of Aberrant Epigenetic Changes and the Tumor Microenvironment in Ovarian Cancer Metastasis异常表观遗传变化及肿瘤微环境在卵巢癌转移中的作用
5
Regulation of epigenetic modifications in the head and neck tumour microenvironment.调控头颈部肿瘤微环境中的表观遗传修饰。
Front Immunol. 2022 Oct 28;13:1050982. doi: 10.3389/fimmu.2022.1050982. eCollection 2022.
6
Epigenetic Modifications in Tumor-Associated Macrophages: A New Perspective for an Old Foe.肿瘤相关巨噬细胞中的表观遗传修饰:老对手的新视角。
Front Immunol. 2022 Jan 24;13:836223. doi: 10.3389/fimmu.2022.836223. eCollection 2022.
7
Epigenetics in prostate cancer: clinical implications.前列腺癌中的表观遗传学:临床意义。
Transl Androl Urol. 2021 Jul;10(7):3104-3116. doi: 10.21037/tau-20-1339.
8
Differential vitamin D 24-hydroxylase/CYP24A1 gene promoter methylation in endothelium from benign and malignant human prostate.良性和恶性人前列腺组织中内皮细胞的维生素 D24-羟化酶/CYP24A1 基因启动子甲基化差异
Epigenetics. 2011 Aug;6(8):994-1000. doi: 10.4161/epi.6.8.16536. Epub 2011 Aug 1.
9
The role of epigenetic modifications in Colorectal Cancer Metastasis.表观遗传修饰在结直肠癌转移中的作用。
Clin Exp Metastasis. 2022 Aug;39(4):521-539. doi: 10.1007/s10585-022-10163-w. Epub 2022 Apr 16.
10
Prostate Carcinogenesis: Insights in Relation to Epigenetics and Inflammation.前列腺癌的发生:与表观遗传学和炎症的关系。
Endocr Metab Immune Disord Drug Targets. 2021;21(2):253-267. doi: 10.2174/1871530320666200719020709.

引用本文的文献

1
Epigenetic Modulation and Bone Metastasis: Evolving Therapeutic Strategies.表观遗传调控与骨转移:不断发展的治疗策略
Pharmaceuticals (Basel). 2025 Jul 31;18(8):1140. doi: 10.3390/ph18081140.
2
Anti-tumor activity of CDYL2b in prostate cancer.CDYL2b在前列腺癌中的抗肿瘤活性。
Cancer Lett. 2025 Aug 12;632:217987. doi: 10.1016/j.canlet.2025.217987.
3
JARID1D-dependent androgen receptor and JunD signaling activation of osteoclast differentiation inhibits prostate cancer bone metastasis through demethylating H3K4.依赖JARID1D的雄激素受体和JunD信号激活破骨细胞分化,通过使H3K4去甲基化抑制前列腺癌骨转移。

本文引用的文献

1
Epigenetics as a mediator of plasticity in cancer.表观遗传学作为癌症可塑性的介体。
Science. 2023 Feb 10;379(6632):eaaw3835. doi: 10.1126/science.aaw3835.
2
RBM3 suppresses stemness remodeling of prostate cancer in bone microenvironment by modulating N6-methyladenosine on CTNNB1 mRNA.RBM3 通过调节 CTNNB1 mRNA 上的 N6-甲基腺苷来抑制骨微环境中前列腺癌的干性重塑。
Cell Death Dis. 2023 Feb 7;14(2):91. doi: 10.1038/s41419-023-05627-0.
3
N-methyladenosine modification in cancer biology: Current status and future perspectives.癌症生物学中的N-甲基腺苷修饰:现状与未来展望
Theranostics. 2025 Jan 1;15(4):1320-1337. doi: 10.7150/thno.104135. eCollection 2025.
4
It Takes Two to Tango: The Interplay between Prostate Cancer and Its Microenvironment from an Epigenetic Perspective.一个巴掌拍不响:从表观遗传学角度看前列腺癌与其微环境之间的相互作用
Cancers (Basel). 2024 Jan 10;16(2):294. doi: 10.3390/cancers16020294.
5
Mechanistic Insights on Localized to Metastatic Prostate Cancer Transition and Therapeutic Opportunities.关于局限性前列腺癌向转移性前列腺癌转变的机制洞察及治疗机会
Res Rep Urol. 2023 Nov 29;15:519-529. doi: 10.2147/RRU.S386517. eCollection 2023.
6
Editorial: Epigenetics in prostate cancer.社论:前列腺癌中的表观遗传学
Front Oncol. 2023 Nov 7;13:1268519. doi: 10.3389/fonc.2023.1268519. eCollection 2023.
7
Role of Ubiquitination and Epigenetics in the Regulation of AhR Signaling in Carcinogenesis and Metastasis: "Albatross around the Neck" or "Blessing in Disguise".泛素化和表观遗传学在芳烃受体信号转导调控致癌和转移中的作用:“脖子上的累赘”还是“因祸得福”。
Cells. 2023 Sep 29;12(19):2382. doi: 10.3390/cells12192382.
Comput Struct Biotechnol J. 2022 Nov 25;20:6578-6585. doi: 10.1016/j.csbj.2022.11.045. eCollection 2022.
4
Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer Phenotypes.循环肿瘤 DNA 中的核小体模式揭示了晚期前列腺癌表型的转录调控。
Cancer Discov. 2023 Mar 1;13(3):632-653. doi: 10.1158/2159-8290.CD-22-0692.
5
Research progress of mA methylation in prostate cancer.前列腺癌中 mA 甲基化的研究进展。
Asian J Androl. 2023 Mar-Apr;25(2):166-170. doi: 10.4103/aja202265.
6
The 5-Hydroxymethylcytosine Landscape of Prostate Cancer.前列腺癌中的 5-羟甲基胞嘧啶景观。
Cancer Res. 2022 Nov 2;82(21):3888-3902. doi: 10.1158/0008-5472.CAN-22-1123.
7
miRNAs in prostate cancer: Intercellular and extracellular communications.微小 RNA 与前列腺癌:细胞间和细胞外通讯。
Int J Urol. 2022 Dec;29(12):1429-1438. doi: 10.1111/iju.15043. Epub 2022 Sep 19.
8
RNA mA regulates transcription via DNA demethylation and chromatin accessibility.RNA mA 通过 DNA 去甲基化和染色质可及性调节转录。
Nat Genet. 2022 Sep;54(9):1427-1437. doi: 10.1038/s41588-022-01173-1. Epub 2022 Sep 7.
9
Comprehensive Analysis of m5C Methylation Regulatory Genes and Tumor Microenvironment in Prostate Cancer.前列腺癌中 m5C 甲基化调控基因与肿瘤微环境的综合分析
Front Immunol. 2022 Jun 10;13:914577. doi: 10.3389/fimmu.2022.914577. eCollection 2022.
10
Inhibition of -Acetyltransferase 10 Suppresses the Progression of Prostate Cancer through Regulation of DNA Replication.乙酰基转移酶 10 的抑制通过调节 DNA 复制抑制前列腺癌的进展。
Int J Mol Sci. 2022 Jun 12;23(12):6573. doi: 10.3390/ijms23126573.